This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Jan;138(1):386-9; discussion 389-90.

doi: 10.1053/j.gastro.2009.11.025. Epub 2009 Nov 20.

Peginterferon Alfa-2B versus peginterferon Alfa-2A with ribavirin for the treatment of chronic hepatitis C: the pursuit of an ideal

Alessio Aghemo¹, Massimo Colombo

Affiliations

PMID: 19932208
DOI: 10.1053/j.gastro.2009.11.025

Comment

Peginterferon Alfa-2B versus peginterferon Alfa-2A with ribavirin for the treatment of chronic hepatitis C: the pursuit of an ideal

Alessio Aghemo et al. Gastroenterology. 2010 Jan.

. 2010 Jan;138(1):386-9; discussion 389-90.

doi: 10.1053/j.gastro.2009.11.025. Epub 2009 Nov 20.

Authors

Alessio Aghemo¹, Massimo Colombo

Affiliation

¹ First Division of Gastroenterology, Fondazione IRCCS Maggiore Hospital, Mangiagalli e Regina Elena, Università degli Studi di Milano, Milan, Italy.

PMID: 19932208
DOI: 10.1053/j.gastro.2009.11.025

No abstract available

PubMed Disclaimer

Comment on

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection.
McHutchison JG, Lawitz EJ, Shiffman ML, Muir AJ, Galler GW, McCone J, Nyberg LM, Lee WM, Ghalib RH, Schiff ER, Galati JS, Bacon BR, Davis MN, Mukhopadhyay P, Koury K, Noviello S, Pedicone LD, Brass CA, Albrecht JK, Sulkowski MS; IDEAL Study Team. McHutchison JG, et al. N Engl J Med. 2009 Aug 6;361(6):580-93. doi: 10.1056/NEJMoa0808010. Epub 2009 Jul 22. N Engl J Med. 2009. PMID: 19625712 Clinical Trial.

Similar articles

Treatment persistence in and cost of therapy for patients with chronic hepatitis C: Peginterferon alfa-2a plus ribavirin versus peginterferon alfa-2b plus ribavirin.
Brixner DI, Ye X, Chu TC, Blumentals WA, Hassanein TI. Brixner DI, et al. Am J Health Syst Pharm. 2009 Dec 15;66(24):2171-8. doi: 10.2146/ajhp080711. Am J Health Syst Pharm. 2009. PMID: 19966085
Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial.
Manns M, Marcellin P, Poordad F, de Araujo ES, Buti M, Horsmans Y, Janczewska E, Villamil F, Scott J, Peeters M, Lenz O, Ouwerkerk-Mahadevan S, De La Rosa G, Kalmeijer R, Sinha R, Beumont-Mauviel M. Manns M, et al. Lancet. 2014 Aug 2;384(9941):414-26. doi: 10.1016/S0140-6736(14)60538-9. Epub 2014 Jun 4. Lancet. 2014. PMID: 24907224 Clinical Trial.
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonçales FL Jr, Häussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J. Fried MW, et al. N Engl J Med. 2002 Sep 26;347(13):975-82. doi: 10.1056/NEJMoa020047. N Engl J Med. 2002. PMID: 12324553 Clinical Trial.
Peginterferon alfa-2a (40KD) (Pegasys) for the treatment of patients with chronic hepatitis C.
Ferenci P. Ferenci P. Int J Clin Pract. 2003 Sep;57(7):610-5. Int J Clin Pract. 2003. PMID: 14529063 Review.
Pegylated interferon plus ribavirin for the treatment of chronic hepatitis C.
Baker DE. Baker DE. Rev Gastroenterol Disord. 2003 Spring;3(2):93-109. Rev Gastroenterol Disord. 2003. PMID: 12776006 Review.

See all similar articles

Cited by

Understanding the role of PNPLA3 genetic variants in patients with chronic hepatitis C infection.
Aghemo A. Aghemo A. Dig Dis Sci. 2012 Aug;57(8):1977-9. doi: 10.1007/s10620-012-2277-2. Epub 2012 Jun 27. Dig Dis Sci. 2012. PMID: 22736017 No abstract available.
Pegylated interferons alpha2a and alpha2b in the treatment of chronic hepatitis C.
Aghemo A, Rumi MG, Colombo M. Aghemo A, et al. Nat Rev Gastroenterol Hepatol. 2010 Sep;7(9):485-94. doi: 10.1038/nrgastro.2010.101. Epub 2010 Jul 20. Nat Rev Gastroenterol Hepatol. 2010. PMID: 20644567 Review.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science